Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-16
2011-11-08
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S284000
Reexamination Certificate
active
08053441
ABSTRACT:
The present invention is directed to novel pyrazolylquinazolinone derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders related to potassium channel.
REFERENCES:
patent: 4766211 (1988-08-01), Zink et al.
patent: WO 2005/009993 (2005-02-01), None
patent: WO 2005/030217 (2005-04-01), None
patent: WO 2005/030791 (2005-04-01), None
patent: WO 2006/097441 (2006-09-01), None
Soliman, E.A. “Some reactions of 2-[3- (3,4-dichlorophenyl) -2- pyrazoline-5-yl] -4H- benzoxazin -4- one”, Chemical Abstract, 1981, vol. 95, Abstract No. 19377a, or 19380a.
Soliman, E.A. “Some reactions of 2-[3- (3,4-dichlorophenyl) -2- pyrazoline-5-yl] -4H- benzoxazin -4- one”, Revue Roumaine de Chimie, (1981), vol. 26, No. 5, pp. 699-703.
Miller, T.R., “Pharmacological and molecular characterization of ATP-sensitive K+ channels . . . ” European Journal of Pharmacology, vol. 370, No. 2, Apr. 9, 1999, pp. 179-185 (only abstract provided).
PCT International Search Report for International Application No. PCT/US2007/062287 dated Jul. 3, 2007.
Wein, A.J.: “Overactive Bladder: Defining the Disease”; The American J. of Managed Care vol. 6, No. 11 (2000): S559-564.
Sui Zhihua
Zhang Xuqing
Bernhardt Emily
Janssen Pharmaceutica N.V.
McKown Jeremy K.
LandOfFree
Pyrazolylquinazolinones as potassium channel openers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolylquinazolinones as potassium channel openers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolylquinazolinones as potassium channel openers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4287021